U.S. to donate millions more Pfizer-BioNTech vaccine doses to poorer nations – CNBC
A child hugs her mother as she gets vaccinated against Covid-19 during a vaccination day in Colombia.
Long Visual Press | Universal Images Group | Getty Images
Pfizer and BioNTech will provide an additional 500 million doses of their Covid-19 vaccine to the U.S. government to be donated to low and lower-middle-income countries.
The move announced Wednesday represents an expansion of the companies’ existing agreement with the U.S. government to provide extra vaccine doses at a not-for-profit price for less-advantaged nations, and brings the total number of doses to be supplied for donation to these countries to a billion.
In line with the initial agreement, the U.S. government will allocate doses of the Pfizer-BioNTech Covid vaccine to 92 low and lower-middle-income countries and the 55 member states of the African Union, Pfizer said in a press statement Wednesday.
Deliveries of the initial 500 million doses began in August, and the total 1 billion doses under the expanded agreement are expected to be delivered by the end of Sept. 2022, the company added.
The first doses allocated through this program arrived in Rwanda in mid-August and since then, more than 30 million doses have been shipped to 22 countries.
Pfizer and BioNTech have an existing agreement in place to supply vaccine doses to the COVAX Facility, a mechanism established by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations and World Health Organization that aims to provide poorer countries with early access to Covid-19 vaccines.
Meanwhile, developed nations like the U.S. and those in Europe have had plentiful supplies of Covid shots since a number of vaccine candidates were developed at breakneck speed and authorized for emergency use last year before being rolled out to their general populations in mass vaccination campaigns.
While a majority of adults in the U.S. and Europe are now fully vaccinated, millions of people around the world do not have such ready access to Covid vaccines which greatly reduce the risk of severe Covid infection, hospitalization and death.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.